Highlights Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq Other stock markets 21:30:00 09/05/2024 BST			5-day change	1st Jan Change
0.398 ^USD	+2.05%		-8.29%	-66.83%

04-02	Centogene Gets Nasdaq Noncompliance Notice	MT
03-19	Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Centogene Gets Nasdaq Noncompliance Notice	04-02	MT
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	03-19	MT
Centogene N.V. Announces the Extension of an Ongoing Partnership with Takeda to Continue Providing Access to Genetic Testing for Patients with Lysosomal Storage Disorders	03-19	CI
Centogene N.V. and the Laboratory of Human Genetics of Infectious Diseases At Institut Imagine Announce Rare Disease Research Collaboration	01-25	CI
Centogene N.V. and The Michael J. Fox Foundation for Parkinson's Research Announces Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics	01-23	CI
Centogene N.V. Provides Earnings Guidance for the Full Year 2023	01-18	CI
Centogene N.V.'s Frontotemporal Dementia Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone	12-13	CI
Centogene, Saudi Arabia's Public Investment Fund Form JV	11-28	MT
Centogene N.V. and Lifera Complete Strategic Joint Venture Transaction	11-28	CI
Centogene N.V. Announces the Discovery of A New Form of Early-Onset Dystonia and Parkinsonism	11-14	CI
Centogene N.V. Expands Multiomic Diagnostic Portfolio with Newly-Launched Transcriptomic Offering	10/10/23	CI
Centogene N.V. Reports Earnings Results for the Half Year Ended June 30, 2023	07/09/23	CI
Centogene N.V. Reaffirms Revenue Guidance for the Year 2023	07/09/23	CI
Upcoming Payrolls Report Lifts Exchange-Traded Funds, Equity Futures Premarket Friday	01/09/23	MT
Centogene N.V. Announces Publication Establishing Lyso-Gb1 as A Predictive Biomarker for Gaucher Disease Patients	01/09/23	CI
Centogene Receives Non-Compliance Notice From Nasdaq	01/09/23	MT
Centogene Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort	12/07/23	CI
Centogene Teams Up With Lifera to Boost Access to Multiomic Testing in Saudi Arabia	03/07/23	MT
Centogene N.V. and Lifera Enter Strategic Collaboration to Increase Access to Leading Data-Driven Multiomic Testing	27/06/23	CI
Centogene N.V. Provides Revenue Guidance for Fiscal Year 2023	16/05/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Centogene N.V.

Equities

CNTG

NL0014040206

Highlights

Filters